Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study Of Senyo Health With Comorbid Alcohol Use Disorder Treatment In Bipolar Patients
Sponsor: Mayo Clinic
Summary
The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving substance use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.
Official title: Senyo Health App - Comorbid Substance Use Disorder Treatment In Bipolar Patients Using A Telehealth Collaborative Care Platform
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-05-16
Completion Date
2029-01-20
Last Updated
2026-04-29
Healthy Volunteers
No
Interventions
Senyo Health App
The Senyo Health app includes asynchronous cognitive behavioral therapy (CBT) modules, contingency management, behavioral activation, and an interface to interact with the care manager for support in treating the comorbidities of bipolar disorder and substance use disorder. Patients will engage with the app daily and have weekly check-in visits with the care manager. After the initial 12 week intervention phase, subjects will be followed for 1 year.
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States